Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation

por Li, Xiaofeng, Zhai, Zhanqiang, Zhu, Youcai, Zhou, Haiou
Publicado 2022

Transcriptomic and immunologic implications of the epithelial–mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma

por Li, Na, Zhai, Zhanqiang, Chen, Yuanbiao, Li, Xiaofeng
Publicado 2022